Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Treasury Shares: 2020-2025

Historic Treasury Shares for Heron Therapeutics (HRTX) over the last 5 years, with Sep 2025 value amounting to $4.0 million.

  • Heron Therapeutics' Treasury Shares rose 159.47% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 159.47%. This contributed to the annual value of $2.0 million for FY2024, which is 41.00% up from last year.
  • Latest data reveals that Heron Therapeutics reported Treasury Shares of $4.0 million as of Q3 2025, which was down 2.88% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Heron Therapeutics' Treasury Shares registered a high of $1.8 billion during Q3 2023, and its lowest value of $570,000 during Q1 2021.
  • Its 3-year average for Treasury Shares is $164.8 million, with a median of $2.7 million in 2023.
  • Per our database at Business Quant, Heron Therapeutics' Treasury Shares soared by 63,301.53% in 2023 and then crashed by 99.91% in 2024.
  • Over the past 5 years, Heron Therapeutics' Treasury Shares (Quarterly) stood at $2.8 million in 2021, then increased by 12.99% to $3.2 million in 2022, then plummeted by 55.64% to $1.4 million in 2023, then soared by 41.00% to $2.0 million in 2024, then surged by 159.47% to $4.0 million in 2025.
  • Its Treasury Shares was $4.0 million in Q3 2025, compared to $4.1 million in Q2 2025 and $3.9 million in Q1 2025.